Cefixime and Clavulanic Acid Tablets

Category: Combination antibiotic therapy (Beta-lactam + Beta-lactamase inhibitor)
Form: Oral tablets

Uses:

• Treatment of bacterial infections that may be resistant to single antibiotics.

• Common indications include:

  • Respiratory tract infections (bronchitis, pneumonia, sinusitis)

  • Ear infections (otitis media)

  • Throat infections (pharyngitis/tonsillitis)

  • Urinary tract infections

  • Skin and soft tissue infections

Mechanism of Action:

• Cefixime: Third-generation cephalosporin

  • Inhibits bacterial cell wall synthesis, causing bacterial death.

  • Effective against Gram-negative bacteria and some Gram-positive bacteria.

• Clavulanic Acid: Beta-lactamase inhibitor

  • Blocks beta-lactamase enzymes produced by resistant bacteria.

  • Prevents destruction of cefixime, enhancing its antibacterial activity.

• The combination extends the spectrum of cefixime, especially against beta-lactamase producing bacteria.

Administration:

• Taken orally, usually once or twice daily, depending on formulation and infection type.

• Can be taken with or without food, preferably at the same time each day.

• Duration of therapy depends on the type and severity of infection, usually 5–10 days.

Side Effects:

• Common: nausea, vomiting, diarrhea, abdominal discomfort.

• Other: mild skin rash, headache.

• Rare but serious: allergic reactions, liver enzyme elevation, severe diarrhea due to C. difficile infection.

Precautions:

• Not recommended for patients with known allergy to cephalosporins or penicillins.

• Use cautiously in patients with kidney or liver impairment.

• Complete the full course to prevent bacterial resistance.

• Report severe diarrhea, rash, or signs of allergic reaction immediately.

Summary:
Cefixime and Clavulanic Acid Tablets combine a cephalosporin antibiotic with a beta-lactamase inhibitor to treat bacterial infections that may involve resistant organisms. Cefixime kills bacteria by inhibiting cell wall synthesis, while clavulanic acid protects it from enzymatic degradation. The combination provides broader antibacterial coverage, is taken orally, and requires completion of the full course for maximum effectiveness.